This can be found among the Granolas, a group of 11 European multinationals, selected by US bank Goldman Sachs, which is made ...

In Europe, the Stoxx Europe 600 climbed 0.2% in morning trading. Alten rose 13.6% and Gaztransport et Technigaz added 10%. On the other hand, Elekta Series B dropped 5.5%, and GSK lost 2.5%. The FTSE ...

China NMPA accepts for review GSK’s Nucala NDA to treat patients with chronic obstructive pulmonary disease: London, UK Friday, February 21, 2025, 09:00 Hrs [IST] GSK plc announ ...

Millie, a modern maternity clinic, secured $12 million in Series A funding led by existing investors RH Capital, TMV, ...

A roundup of recent health news highlights policy changes affecting FDA language use, drug industry meetings with President ...

GSK (GSK) announced that the China National Medical Products Administration, CNMPA, has accepted for review the new drug application for the ...

(Alliance News) - GSK PLC on Thursday said its monoclonal antibody Nucala, also known as mepolizumab, has been accepted for review in China.

GSK's revenue and EPS exceeded my expectations and those of analysts. Check out the reasons why I am upgrading GSK stock's ...

Shares in TSMC (TSM, 2330.TW) rose more than 2% on Monday, after it was reported that the chipmaker was considering taking a ...

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

The Department of Homeland Security is asking for the Internal Revenue Service to help crack down on immigration, according ...